BioSpace News Archive

Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced the appointment of Mark A. Doheny as Chief Financial Officer.

Canadian Brand Oral Science Has Delivered Quality Products to B2B Customers for Years. Now, They’re Offering Their Superior Dental Solutions to Consumers.

Medela LLC announced the release of new data in a peer-reviewed SAWC Fall published poster and white paper supplement to Wounds demonstrating the Medela Invia Liberty Negative Pressure Wound Therapy (NPWT) System innovates the current NPWT standard of care

ENGLEWOOD, CO / ACCESSWIRE / November 10, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on womens intimate health, today announced that Scott Durbin, chief executive officer, will participate in the Alliance Group Partners Virtual Healthcare Symposium on November 19, 2020.

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products for the critical care market, today announced that data from the 24-hour open-label portion of the HELP (Hemodynamic Evaluation of Levosimendan in PH-HFpEF) Study will be presented during the American Heart Association (AHA) Scientific Sessions 2020

Atlantic Research Group, a global full-service contract research organization, named three leading scientists and researchers as members of its new Scientific Advisory Board.

CEVEC Pharma GmbH (CEVEC) today announced the signing of an option and license agreement with Roche for the use of its newly launched ELEVECTA(R) Technology for large scale manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications.

Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor (CAR) T cell therapies for solid and liquid tumors, today announced its plans to present CoupledCAR® solid tumor CAR-T clinical data at two key oncology conferences.

Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced that management will participate in four upcoming virtual investor conferences.

Ascendum Solutions, a global digital innovation firm, today announced the product release of SafeReturnTM, a mobile application designed to help limit the spread of COVID-19 and comply with New Jersey Executive Order No. 192 to protect worker safety.